ITPA gene variant may protect against anemia induced during pegylated interferon Alfa and Ribavirin combination treatment in Ukrainian patients with chronic hepatitis C
Abstract:The aim of this study was to clarify the association between the inosine triphosphate pyrophosphatase (ITPA) (23,7 %) comparing to the group of patients with anemia (7,3 %). The respective allele frequency in control group (13,2 %) was almost 3-fold higher (P < 0,05)
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.